Each vaccine was composed of 4 × 106 irradiated autologous tumor cells, harvested from a metastatic lymph node or distant metastasis, and two biocompatible macrocapsules containing each 0.8 × 106 cells, genetically engineered to secrete at least 20 ng of GM-CSF per day. Here, CSF2 is linked to neoplasm.